Consistent with this, targeting of OXSR1 or STK39 alone had no detrimental effect on the proliferation of human AML cells that express both OXSR1 and STK39 (Fig. 2d, e and Supplementary Fig. 2b–h). The gene discussed is STK39; the disease is acute myeloid leukemia.